European Neuropsychopharmacology

Journal Title：European Neuropsychopharmacology

European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery.

《欧洲神经精神药理学》是欧洲神经精神药理学学院 (ECNP) 的官方出版物。根据学院的使命，该期刊专注于临床和基础科学贡献，以促进我们对大脑功能和人类行为的理解，并使其转化为更好的治疗方法和增强精神病学对公共卫生的影响。近年来，神经科学和基因组学的基础知识和可用的实验技术取得了令人振奋的进展。然而，这些发现的临床转化速度并不快。该期刊旨在通过宣传有望对我们理解精神障碍的生物学基础以及治疗方法的开发和改进产生重大影响的发现来缩小这一差距，理想情况下为预防和康复铺平道路。

European Neuropsychopharmacology创刊于1990年，由Elsevier出版商出版，收稿方向涵盖医学 - 精神病学全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。平均审稿速度 偏慢,4-8周 ，影响因子指数6.1，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。